Transcutaneous Auricular Vagus Nerve Stimulation in Pediatric Patients: A Systematic Review of Clinical Treatment Protocols and Stimulation Parameters

被引:6
|
作者
Sigrist, Christine [1 ,2 ]
Torki, Bushra [1 ,2 ]
Bolz, Lars -Oliver [3 ]
Jeglorz, Tobias [4 ]
Bolz, Armin [1 ,3 ]
Koenig, Julian [1 ,2 ]
机构
[1] Univ Cologne, Fac Med, Dept Child & Adolescent Psychiat Psychosomat & Psy, Robert Koch Str 10,Bldg 53,Room 1-009, D-50931 Cologne, Germany
[2] Univ Cologne, Univ Hosp Cologne, Robert Koch Str 10,Bldg 53,Room 1-009, D-50931 Cologne, Germany
[3] tVNS Technol GmbH, Erlangen, Germany
[4] Sasse Elekt GmbH, Schwabach, Germany
来源
NEUROMODULATION | 2023年 / 26卷 / 03期
关键词
Children and adolescents; neurodevelopment; pediatrics; transcutaneous vagus nerve stimulation; EPILEPSY; EFFICACY; THERAPY; SPAN;
D O I
10.1016/j.neurom.2022.07.007
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Background: Noninvasive transcutaneous vagus nerve stimulation (tVNS) has promising therapeutic potential in a wide range of applications across somatic and psychiatric conditions. Compared with invasive vagus nerve stimulation, good safety and tolerability profiles also support the use of tVNS in pediatric patients. Potential neurodevelopment-specific needs, however, raise concerns regarding the age-appropriate adjustment of treatment protocols and applied stimulation parameters.Objective: In this study, we aimed to review registered trials and published studies to synthesize existing tVNS treatment protocols and stimulation parameters applied in pediatric patients.Materials and Methods: A systematic search of electronic data bases (PubMed, Scopus, MEDLINE, Cochrane Library, and Psy-cINFO) and ClinicalTrials was conducted. Information on patient and study-level characteristics (eg, clinical condition, sample size), the tVNS device (eg, brand name, manufacturer), stimulation settings (eg, pulse width, stimulation intensity), and stimu-lation protocol (eg, duration, dosage of stimulation) was extracted.Results: We identified a total of 15 publications (four study protocols) and 15 registered trials applying tVNS in pediatric patients (<18 years of age). Most of these studies did not exclusively address pediatric patients. None of the studies elaborated on neurodevelopmental aspects or justified the applied protocol or stimulation parameters for use in pediatric patients.Conclusions: No dedicated pediatric tVNS devices exist. Neither stimulation parameters nor stimulation protocols for tVNS are properly justified in pediatric patients. Evidence on age-dependent stimulation effects of tVNS under a neurodevelopment framework is warranted. We discuss the potential implications of these findings with clinical relevance, address some of the challenges of tVNS research in pediatric populations, and point out key aspects in future device development and research in addition to clinical studies on pediatric populations.
引用
收藏
页码:507 / 517
页数:11
相关论文
共 50 条
  • [1] TRANSCUTANEOUS AURICULAR VAGUS NERVE STIMULATION IN CHILDREN AND ADOLESCENTS - A SYSTEMATIC REVIEW OF TREATMENT PROTOCOLS AND STIMULATION PARAMETERS
    Sigrist, Christine
    Torki, Bouchra
    Bolz, Armin
    Bolz, Lars O.
    Jeglorz, Tobias
    Bender, Stephan
    Koenig, Julian
    PSYCHOSOMATIC MEDICINE, 2022, 84 (05): : A35 - A35
  • [2] Clinical application of transcutaneous auricular vagus nerve stimulation: a scoping review
    Gerges, Ashraf N. H.
    Williams, Ellen
    Hillier, Susan
    Uy, Jeric
    Hamilton, Taya
    Chamberlain, Saran
    Hordacre, Brenton
    DISABILITY AND REHABILITATION, 2024, 46 (24) : 5730 - 5760
  • [3] Transcutaneous Auricular Vagus Nerve Stimulation
    Ellrich, Jens
    JOURNAL OF CLINICAL NEUROPHYSIOLOGY, 2019, 36 (06) : 437 - 442
  • [4] Transcutaneous auricular vagus nerve stimulation: Clinical applications and mechanisms
    Zhang, Yu-zhengheng
    Zou, Ning-yi
    Rong, Pei-jing
    Li, Shao-yuan
    WORLD JOURNAL OF ACUPUNCTURE-MOXIBUSTION, 2024, 34 (02) : 174 - 175
  • [5] Transcutaneous auricular vagus nerve stimulation for epilepsy
    Zhang, Qing
    Luo, Xue
    Wang, Xiao-hui
    Li, Jing-ya
    Qiu, Hui
    Yang, Dong-dong
    SEIZURE-EUROPEAN JOURNAL OF EPILEPSY, 2024, 119 : 84 - 91
  • [6] Transcutaneous Auricular Vagus Nerve Stimulation (taVNS) for the Treatment of Pediatric Nephrotic Syndrome (NS)
    Sethna, Christine B.
    Merchant, Kumail
    Zanos, Stavros
    Datta-Chaudhuri, Timir
    Singer, Pamela
    Castellanos, Laura J.
    Frank, Rachel
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2021, 32 (10): : 513 - 513
  • [7] Transcutaneous Auricular Vagus Nerve Stimulation for Managing Pain: A Scoping Review
    Chen, Jie
    Kuang, Huan
    Chen, Aokun
    Dungan, Jennifer
    Cousin, Lakeshia
    Cong, Xiaomei
    Patel, Param
    Starkweather, Angela
    PAIN MANAGEMENT NURSING, 2025, 26 (01) : 33 - 39
  • [8] Transcutaneous auricular vagus nerve stimulation (taVNS) for the treatment of pediatric nephrotic syndrome: a pilot study
    Merchant K.
    Zanos S.
    Datta-Chaudhuri T.
    Deutschman C.S.
    Sethna C.B.
    Bioelectronic Medicine, 2022, 8 (01)
  • [9] The anatomical basis for transcutaneous auricular vagus nerve stimulation
    Butt, Mohsin F.
    Albusoda, Ahmed
    Farmer, Adam D.
    Aziz, Qasim
    JOURNAL OF ANATOMY, 2020, 236 (04) : 588 - 611
  • [10] Safety of transcutaneous auricular vagus nerve stimulation (taVNS): a systematic review and meta-analysis
    Kim, Angela Yun
    Marduy, Anna
    de Melo, Paulo S.
    Gianlorenco, Anna Carolyna
    Kim, Chi Kyung
    Choi, Hyuk
    Song, Jae-Jun
    Fregni, Felipe
    SCIENTIFIC REPORTS, 2022, 12 (01):